UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in KYMR — Kymera Therapeutics, Inc.
CIK 861177
NEW YORK, NY
Position in KYMR
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$84,496,420
+$11,545,046 QoQ
Shares Held
736,866
-15.9% QoQ
Ownership
0.886%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#25
of 273 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 49%
Shared 0%
None 51%
Common Shares in KYMR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,385,897,555 across 206 Biotechnology names. KYMR ranks #9 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,086,683 | $1,533,248,041 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
716,560 | $446,803,817 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
727,848 | $219,104,078 | |
| 4 | INCY |
Incyte Corp
|
1,508,720 | $171,028,494 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
912,335 | $170,862,094 | |
| 6 | INSM |
INSMED Inc
|
1,335,071 | $142,345,265 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,454,672 | $115,340,938 | |
| 8 | MRNA |
Moderna, Inc.
|
1,521,849 | $106,575,080 |
All Filings in KYMR
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $84,496,420 | 736,866 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $72,951,374 | 875,872 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $71,001,464 | 912,498 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $48,888,926 | 863,762 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $35,737,970 | 818,927 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $24,534,572 | 896,404 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $16,279,749 | 404,667 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $20,282,274 | 428,529 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $12,942,149 | 433,573 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $7,233,504 | 179,938 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $4,493,686 | 176,500 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $2,637,285 | 189,733 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $4,058,376 | 176,528 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $5,230,521 | 176,528 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $4,481,991 | 179,567 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $3,647,453 | 167,545 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,826,236 | 194,324 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $18,207,881 | 430,243 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $16,891,575 | 266,051 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $15,641,813 | 266,289 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $13,678,890 | 282,039 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||